There are many reasons to own Abbott Laboratories (NYSE: ABT), but they all boil down to one thing: consistent market-beating returns.

Abbott Laboratories has reported sales of $10.6bn for the third quarter (Q3) of 2024, as against $10.4bn in Q2 2024, with ...

Abbott Laboratories ABT reported better-than-expected third-quarter results on Wednesday. The company posted sales of $10.64 ...

Q3 2024 Earnings Call Transcript October 16, 2024 Abbott Laboratories beats earnings expectations. Reported EPS is $1.21, ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...

Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) today and set a price target ...

United Airlines Holdings is up more than +8% after reporting stronger-than-expected Q3 adjusted EPS and initiating a $1.5 billion stock buyback program. Also, bank stocks are climbing today after ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

Wall Street trading got off to a mixed start on Wednesday as the Dow Jones tried to claw back some of the heavy losses ...

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 20 points on Wednesday. The Dow traded up 0.05 ...

Morgan Stanley (NYSE:MS) stock rose 4% after the lender's profit surpassed estimates on a bumper third quarter for investment ...